Gupta Amit sold $71K of CDLX
Gupta Amit (Chief Executive Officer) sold 16,138 shares of Cardlytics, Inc. (CDLX) at an average of $4.39 ($4.39–$4.40) across 2 trades over 2026-07-02 to 2026-07-06.
How this was made
The 30-second read
Why it matters
Traders may monitor for follow-on insider activity, but the disclosure alone does not change the company’s earnings outlook or business trajectory based on the provided text.
Market read
A new Form 4 insider sale was disclosed, which can slightly influence sentiment but is not a fundamental catalyst in the article.
What to watch
The article does not state whether the sale was part of a broader pattern, tax event, or compensation schedule; it also lacks any context on total insider holdings changes beyond the post-trade figure.
Background
The article is a primary-source SEC Form 4 insider transaction for Cardlytics, Inc. (CDLX).
Ticker impact
Cardlytics CEO Amit Gupta filed a Form 4 selling 16,138 shares in open-market trades at about $4.3944/share.
Likely limited near-term impact; any effect is sentiment-driven and typically fades unless repeated or paired with other disclosures.
The filing is a routine open-market sale (no 10b5-1 plan stated) with small-to-moderate dollar value and no accompanying company-specific fundamental catalyst in the text.
Market effects
No sector read-across; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Insider sales can be planned for liquidity/tax and do not necessarily signal deteriorating fundamentals, especially when the filing is routine.
Key entities
- issuerCardlytics, Inc.
Subject of the Form 4 insider transaction; CEO Amit Gupta sold shares in open-market trades.
- insiderAmit Gupta
CEO of Cardlytics; reported open-market sale of 16,138 shares at ~$4.3944/share.
